Virginia Cancer Institute

Information may not be reliable

Thank You for choosing Virginia Cancer InstituteOur MissionVCI NewsAppointmentsEmergencies & Phone CallsFinancial InformationLocationsPrescription RefillsPatient Rights and ResponsibilitiesPatient InformationPrivacy PolicyWebsite Information
Physicians Radiological Services
What is Cancer?Diagnosing CancerIntroduction to Cancer TreatmentOptimizing TreatmentQuestions to AskA Word about Clinical TrialsGetting a Second Opinion
General Cancer InformationBladder CancerBone CancerBrain CancerBreast CancerCervical CancerColon CancerEsophageal CancerGastric CancerHead & Neck CancerHodgkin's LymphomaLeukemiaLung CancerMelanomaMultiple Myeloma

Myelodysplastic SyndromeNon-Hodgkin's LymphomaOvarian CancerPancreatic CancerProstate CancerRectal CancerRenal CancerSarcomaUterine CancerSkin CancerTesticular CancerThyroid Cancer
Treatment OverviewChemotherapyRadiation TherapySurgeryHormonal TherapyTargeted TherapyStem Cell TransplantationSide Effects of TreatmentComplementary & Alternative
OverviewScreening ToolsDiagnostic & Monitoring Tests
Latest Cancer NewsAnal CancerBladder CancerBone CancerBrain and CNS CancersBreast CancerCervical CancerColon CancerComplementary Alternative MedicineEsophageal CancerGastric CancerGene TherapyHead and Neck CancerHIV Related CancersHodgkin's Lymphoma

LeukemiaLiver CancerLung CancerLung Cancer - Non-Small CellLung Cancer - Small CellMalignant MesotheliomaMelanomaMultiple MyelomaMyelodysplastic SyndromeNeuroblastomaNon-Hodgkin's LymphomaOvarian CancerPancreatic CancerProstate CancerRectal Cancer

Renal CancerRetinoblastomaSarcomaScreening & PreventionSkin CancerStem Cell TransplantSupportive CareTesticular CancerThyroid CancerUterine CancerVaginal Cancer
IntroductionWhat Are Clinical Trials?Phases of Clinical TrialsHow Are Clinical Trials Conducted?Clinical Trials SafeguardsParticipating in Clinical TrialsThe Cost of Clinical TrialsFinding Specific Clinical TrialsThe Future of Clinical TrialsClinical Trials Database
LINCOverviewCaregiversHealing EnvironmentsSupport GroupsJournalingBirth Control and SexualityHome HealthFinancial & Insurance IssuesAdvanced DirectivesInspirationMovement & ExerciseLife after TreatmentOnline Resources

At Virginia Cancer Institute, we provide treatment, support, and follow-up care for people with cancer and blood disorders. Our purpose is to provide our patients with care that includes efficiency and compassion. The Virginia Cancer Institute is committed to offering care in an atmosphere of professionalism, encouragement, and understanding. Virginia Cancer Institute serves you by offering the best treatment plans, answering questions to your satisfaction, and respecting your informed decisions.

Virginia Cancer Institute's mission is to deliver high-quality, comprehensive medical care while maintaining our patients' quality of life. We offer a team approach for your cancer treatment by involving experts in medical oncology, hematology, chemotherapy, and clinical research.

Provide information about our programs, special services, physicians, and other health care professionals.
Help you understand your diagnosis and treatment choices.

We strive to promote respect, understanding, honesty, compassion, integrity, teamwork, individuality, and confidentiality at all times. We will remain committed to our purpose by remaining innovative and continuously increasing our awareness of technological advancements and the latest treatment methods. The physicians and staff continue to strive to remain dedicated to this mission.

Virginia Cancer Institute is dedicated to understanding the causes, prevention, and detection of cancer and to improving the quality of life for individuals living with cancer. Virginia Cancer Institute strives to be in the forefront of modern cancer care through the thoughtful introduction of promising new methods of treatment, the active participation in clinical research, the recruitment, development and education of highly trained oncology personnel, and the use of state-of-the art medical equipment.

Sprycel Approved for Initial Treatment of Chronic Myeloid Leukemia (11/05/2010)
The U.S. Food and Drug Administration has expanded the approval of Sprycel® (dasatinib) to include the initial treatment of patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
FDA Adds Warning to Drugs Used in the Treatment of Prostate Cancer (11/04/2010)
Combined Hormone Therapy Linked with More Advanced Breast Cancer (11/03/2010)
In addition to increasing the likelihood of breast cancer, postmenopausal hormone therapy with estrogen plus progestin may also be linked with more advanced breast cancers. These findings were recently published in the Journal of the American Medical Association.